Vanguard Global Advisers »

Contineum Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $134k 10k 13.06

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Vanguard Group
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Contineum Therapeutics